Strategic Acquisition Ekium Group’s acquisition of Scitech Engineering Ltd signals a strengthened life sciences capability and broader geographic reach, presenting cross-sell opportunities to existing Ekium clients in pharma, biotech, and regulated industries.

End-to-End Project Scitech-Ekium offers integrated services from feasibility and design through construction, validation and ongoing operation, enabling sales pitches around single-source accountability for complex pharmaceutical and life sciences facility projects.

Veterinary Vaccine Potential Recent partnership with The Pirbright Institute to build the Centre for Veterinary Vaccine Innovation and Manufacturing highlights a growing focus on vaccine manufacturing capabilities that could open opportunities with CROs, biotechs, and government-funded health programs.

Regulatory Expertise Combined heritage in regulatory compliance and multidisciplinary engineering positions Scitech-Ekium to target regulated pharma and biotech clients seeking validated processes, GMP-aligned facilities, and rapid time-to-delivery.

Talent & Culture Investments in HR leadership, safety coordination, and graduate programs (Xcellerate) indicate a strong people-first approach, enabling sales conversations around scalable staffing, training, and organizational capability for large-scale projects.